Associate Dean of Assessment and Quality Professor of Clinical Pharmacy Department of Clinical Pharmacy Practice University of California Irvine School of Pharmacy & Pharmaceutical Sciences Irvine, CA.
Director, Division of Research Kaiser Permanente Northern California Oakland, CA.
J Manag Care Spec Pharm. 2021 May;27(5):689-690. doi: 10.18553/jmcp.2021.27.5.689.
No funding was received for the writing of this letter. All authors were members of the National Academies study committee to which this letter refers, with Shortliffe as the chair. All committee members who contributed to the report were themselves vetted for potential conflicts of interest, as is described in the recently published version of the report. Lieu is an employee of Kaiser Permanente and the content does not represent the official views of Kaiser Permanente. The other authors have nothing to disclose.
本信函的撰写并未接受任何资助。所有作者均为该信函所提及的美国国家科学院研究委员会的成员，其中 Shortliffe 为主席。正如报告的最新版本中所描述的，所有对报告做出贡献的委员会成员都经过了潜在利益冲突的审查。Lieu 是 Kaiser Permanente 的员工，其内容不代表 Kaiser Permanente 的官方观点。其他作者没有需要披露的信息。
